Fresenius Medical Care Financials - Benzinga

Fresenius Medical Care AG

FMSNYSE

Trade with Public

Trade with Public

$22.45

-0.21-0.93%

At close: Sep 4, 5:00 PM EST

$22.82

0.160.71%

Pre-Market: 6:18 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

Fresenius Medical Care Financials

Fresenius Medical Care (FMS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.

Benzinga Newsdesk

PRO
Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.870B Est

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.870 billion estimate.

Benzinga Newsdesk

PRO
Fresenius Medical Care Q1 Adj. EPS $0.53 Misses $0.59 Estimate, Sales $5.401B Miss $5.720B Estimate

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 20.45 percent increase over earnings of $0.44 per share

Benzinga Newsdesk

PRO
Fresenius Medical Care Sees FY2026 Sales $23.764B vs $22.640B Est

Fresenius Medical Care (NYSE:FMS) sees FY2026 sales of $23.764 billion vs $22.640 billion analyst estimate.

Benzinga Newsdesk